Global Therapeutic Plasma Exchange Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely performed in the treatment of various chronic diseases as first line or as second line of therapy or as a supportive treatment.
Scope of the Report:
This report studies the Therapeutic Plasma Exchange market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Therapeutic Plasma Exchange market by product type and applications/end industries.
Therapeutic plasma exchange (TPE) has wide applications in the treatment of neurological, renal, hematological, and metabolic disorders. The indications for using therapeutic plasma exchange procedures as a line of treatment are regulated through guidelines provided by the American Society for Apheresis (ASFA). It categorizes the indications in four parts: category I to IV. Category I and II depict TPE as first or second line of treatment for many neurological, renal, and hematological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura (TTP).
The global Therapeutic Plasma Exchange market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Therapeutic Plasma Exchange.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
Scope of the Report:
This report studies the Therapeutic Plasma Exchange market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Therapeutic Plasma Exchange market by product type and applications/end industries.
Therapeutic plasma exchange (TPE) has wide applications in the treatment of neurological, renal, hematological, and metabolic disorders. The indications for using therapeutic plasma exchange procedures as a line of treatment are regulated through guidelines provided by the American Society for Apheresis (ASFA). It categorizes the indications in four parts: category I to IV. Category I and II depict TPE as first or second line of treatment for many neurological, renal, and hematological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura (TTP).
The global Therapeutic Plasma Exchange market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Therapeutic Plasma Exchange.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Asahi Kasei Corporation
- Baxter International
- Terumo Corporation
- B. Braun
- Fresenius Kabi
- Kawasumi Laboratories
- Haemonetics Corporation
- Cerus Corporation
- Hemacare Corporation
- Medica S.p.A.
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
- Neurological Disorders
- Renal Disorders
- Hematology Disorders
- Metabolic Disorders
- Others
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
1 THERAPEUTIC PLASMA EXCHANGE MARKET OVERVIEW
1.1 Product Overview and Scope of Therapeutic Plasma Exchange
1.2 Classification of Therapeutic Plasma Exchange by Types
1.2.1 Global Therapeutic Plasma Exchange Revenue Comparison by Types (2017-2023)
1.2.2 Global Therapeutic Plasma Exchange Revenue Market Share by Types in 2017
1.2.3 Neurological Disorders
1.2.4 Renal Disorders
1.2.5 Hematology Disorders
1.2.6 Metabolic Disorders
1.2.7 Others
1.3 Global Therapeutic Plasma Exchange Market by Application
1.3.1 Global Therapeutic Plasma Exchange Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Therapeutic Plasma Exchange Market by Regions
1.4.1 Global Therapeutic Plasma Exchange Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Therapeutic Plasma Exchange Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Therapeutic Plasma Exchange Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Therapeutic Plasma Exchange Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Therapeutic Plasma Exchange Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Therapeutic Plasma Exchange Status and Prospect (2013-2023)
1.5 Global Market Size of Therapeutic Plasma Exchange (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Asahi Kasei Corporation
2.1.1 Business Overview
2.1.2 Therapeutic Plasma Exchange Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Asahi Kasei Corporation Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.2 Baxter International
2.2.1 Business Overview
2.2.2 Therapeutic Plasma Exchange Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Baxter International Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.3 Terumo Corporation
2.3.1 Business Overview
2.3.2 Therapeutic Plasma Exchange Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Terumo Corporation Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.4 B. Braun
2.4.1 Business Overview
2.4.2 Therapeutic Plasma Exchange Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 B. Braun Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.5 Fresenius Kabi
2.5.1 Business Overview
2.5.2 Therapeutic Plasma Exchange Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Fresenius Kabi Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kawasumi Laboratories
2.6.1 Business Overview
2.6.2 Therapeutic Plasma Exchange Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Kawasumi Laboratories Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.7 Haemonetics Corporation
2.7.1 Business Overview
2.7.2 Therapeutic Plasma Exchange Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Haemonetics Corporation Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cerus Corporation
2.8.1 Business Overview
2.8.2 Therapeutic Plasma Exchange Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cerus Corporation Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.9 Hemacare Corporation
2.9.1 Business Overview
2.9.2 Therapeutic Plasma Exchange Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hemacare Corporation Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.10 Medica S.p.A.
2.10.1 Business Overview
2.10.2 Therapeutic Plasma Exchange Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Medica S.p.A. Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITION, BY PLAYERS
3.1 Global Therapeutic Plasma Exchange Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Therapeutic Plasma Exchange Players Market Share
3.2.2 Top 10 Therapeutic Plasma Exchange Players Market Share
3.3 Market Competition Trend
4 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE BY REGIONS
4.1 Global Therapeutic Plasma Exchange Revenue and Market Share by Regions
4.2 North America Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
4.3 Europe Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
4.5 South America Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE REVENUE BY COUNTRIES
5.1 North America Therapeutic Plasma Exchange Revenue by Countries (2013-2018)
5.2 USA Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
5.3 Canada Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
5.4 Mexico Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
6 EUROPE THERAPEUTIC PLASMA EXCHANGE REVENUE BY COUNTRIES
6.1 Europe Therapeutic Plasma Exchange Revenue by Countries (2013-2018)
6.2 Germany Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
6.3 UK Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
6.4 France Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
6.5 Russia Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
6.6 Italy Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE REVENUE BY COUNTRIES
7.1 Asia-Pacific Therapeutic Plasma Exchange Revenue by Countries (2013-2018)
7.2 China Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
7.3 Japan Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
7.4 Korea Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
7.5 India Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA THERAPEUTIC PLASMA EXCHANGE REVENUE BY COUNTRIES
8.1 South America Therapeutic Plasma Exchange Revenue by Countries (2013-2018)
8.2 Brazil Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
8.3 Argentina Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
8.4 Colombia Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE THERAPEUTIC PLASMA EXCHANGE BY COUNTRIES
9.1 Middle East and Africa Therapeutic Plasma Exchange Revenue by Countries (2013-2018)
9.2 Saudi Arabia Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
9.3 UAE Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
9.4 Egypt Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
9.5 Nigeria Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
9.6 South Africa Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
10 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SEGMENT BY TYPE
10.1 Global Therapeutic Plasma Exchange Revenue and Market Share by Type (2013-2018)
10.2 Global Therapeutic Plasma Exchange Market Forecast by Type (2018-2023)
10.3 Neurological Disorders Revenue Growth Rate (2013-2023)
10.4 Renal Disorders Revenue Growth Rate (2013-2023)
10.5 Hematology Disorders Revenue Growth Rate (2013-2023)
10.6 Metabolic Disorders Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SEGMENT BY APPLICATION
11.1 Global Therapeutic Plasma Exchange Revenue Market Share by Application (2013-2018)
11.2 Therapeutic Plasma Exchange Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Specialty Clinics Revenue Growth (2013-2018)
11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)
12 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE FORECAST (2018-2023)
12.1 Global Therapeutic Plasma Exchange Market Size Forecast (2018-2023)
12.2 Global Therapeutic Plasma Exchange Market Forecast by Regions (2018-2023)
12.3 North America Therapeutic Plasma Exchange Revenue Market Forecast (2018-2023)
12.4 Europe Therapeutic Plasma Exchange Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Therapeutic Plasma Exchange Revenue Market Forecast (2018-2023)
12.6 South America Therapeutic Plasma Exchange Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Therapeutic Plasma Exchange Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Therapeutic Plasma Exchange
1.2 Classification of Therapeutic Plasma Exchange by Types
1.2.1 Global Therapeutic Plasma Exchange Revenue Comparison by Types (2017-2023)
1.2.2 Global Therapeutic Plasma Exchange Revenue Market Share by Types in 2017
1.2.3 Neurological Disorders
1.2.4 Renal Disorders
1.2.5 Hematology Disorders
1.2.6 Metabolic Disorders
1.2.7 Others
1.3 Global Therapeutic Plasma Exchange Market by Application
1.3.1 Global Therapeutic Plasma Exchange Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Therapeutic Plasma Exchange Market by Regions
1.4.1 Global Therapeutic Plasma Exchange Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Therapeutic Plasma Exchange Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Therapeutic Plasma Exchange Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Therapeutic Plasma Exchange Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Therapeutic Plasma Exchange Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Therapeutic Plasma Exchange Status and Prospect (2013-2023)
1.5 Global Market Size of Therapeutic Plasma Exchange (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Asahi Kasei Corporation
2.1.1 Business Overview
2.1.2 Therapeutic Plasma Exchange Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Asahi Kasei Corporation Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.2 Baxter International
2.2.1 Business Overview
2.2.2 Therapeutic Plasma Exchange Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Baxter International Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.3 Terumo Corporation
2.3.1 Business Overview
2.3.2 Therapeutic Plasma Exchange Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Terumo Corporation Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.4 B. Braun
2.4.1 Business Overview
2.4.2 Therapeutic Plasma Exchange Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 B. Braun Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.5 Fresenius Kabi
2.5.1 Business Overview
2.5.2 Therapeutic Plasma Exchange Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Fresenius Kabi Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kawasumi Laboratories
2.6.1 Business Overview
2.6.2 Therapeutic Plasma Exchange Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Kawasumi Laboratories Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.7 Haemonetics Corporation
2.7.1 Business Overview
2.7.2 Therapeutic Plasma Exchange Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Haemonetics Corporation Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cerus Corporation
2.8.1 Business Overview
2.8.2 Therapeutic Plasma Exchange Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cerus Corporation Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.9 Hemacare Corporation
2.9.1 Business Overview
2.9.2 Therapeutic Plasma Exchange Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hemacare Corporation Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
2.10 Medica S.p.A.
2.10.1 Business Overview
2.10.2 Therapeutic Plasma Exchange Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Medica S.p.A. Therapeutic Plasma Exchange Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET COMPETITION, BY PLAYERS
3.1 Global Therapeutic Plasma Exchange Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Therapeutic Plasma Exchange Players Market Share
3.2.2 Top 10 Therapeutic Plasma Exchange Players Market Share
3.3 Market Competition Trend
4 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE BY REGIONS
4.1 Global Therapeutic Plasma Exchange Revenue and Market Share by Regions
4.2 North America Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
4.3 Europe Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
4.5 South America Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE REVENUE BY COUNTRIES
5.1 North America Therapeutic Plasma Exchange Revenue by Countries (2013-2018)
5.2 USA Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
5.3 Canada Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
5.4 Mexico Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
6 EUROPE THERAPEUTIC PLASMA EXCHANGE REVENUE BY COUNTRIES
6.1 Europe Therapeutic Plasma Exchange Revenue by Countries (2013-2018)
6.2 Germany Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
6.3 UK Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
6.4 France Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
6.5 Russia Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
6.6 Italy Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE REVENUE BY COUNTRIES
7.1 Asia-Pacific Therapeutic Plasma Exchange Revenue by Countries (2013-2018)
7.2 China Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
7.3 Japan Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
7.4 Korea Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
7.5 India Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA THERAPEUTIC PLASMA EXCHANGE REVENUE BY COUNTRIES
8.1 South America Therapeutic Plasma Exchange Revenue by Countries (2013-2018)
8.2 Brazil Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
8.3 Argentina Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
8.4 Colombia Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE THERAPEUTIC PLASMA EXCHANGE BY COUNTRIES
9.1 Middle East and Africa Therapeutic Plasma Exchange Revenue by Countries (2013-2018)
9.2 Saudi Arabia Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
9.3 UAE Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
9.4 Egypt Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
9.5 Nigeria Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
9.6 South Africa Therapeutic Plasma Exchange Revenue and Growth Rate (2013-2018)
10 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SEGMENT BY TYPE
10.1 Global Therapeutic Plasma Exchange Revenue and Market Share by Type (2013-2018)
10.2 Global Therapeutic Plasma Exchange Market Forecast by Type (2018-2023)
10.3 Neurological Disorders Revenue Growth Rate (2013-2023)
10.4 Renal Disorders Revenue Growth Rate (2013-2023)
10.5 Hematology Disorders Revenue Growth Rate (2013-2023)
10.6 Metabolic Disorders Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SEGMENT BY APPLICATION
11.1 Global Therapeutic Plasma Exchange Revenue Market Share by Application (2013-2018)
11.2 Therapeutic Plasma Exchange Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Specialty Clinics Revenue Growth (2013-2018)
11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)
12 GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE FORECAST (2018-2023)
12.1 Global Therapeutic Plasma Exchange Market Size Forecast (2018-2023)
12.2 Global Therapeutic Plasma Exchange Market Forecast by Regions (2018-2023)
12.3 North America Therapeutic Plasma Exchange Revenue Market Forecast (2018-2023)
12.4 Europe Therapeutic Plasma Exchange Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Therapeutic Plasma Exchange Revenue Market Forecast (2018-2023)
12.6 South America Therapeutic Plasma Exchange Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Therapeutic Plasma Exchange Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Therapeutic Plasma Exchange Picture
Table Product Specifications of Therapeutic Plasma Exchange
Table Global Therapeutic Plasma Exchange and Revenue (Million USD) Market Split by Product Ty
Figure Therapeutic Plasma Exchange Picture
Table Product Specifications of Therapeutic Plasma Exchange
Table Global Therapeutic Plasma Exchange and Revenue (Million USD) Market Split by Product Ty
